◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Crescita Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 19.6M 17.5M 23.5M 16.8M
Operating Revenue 19.6M 17.5M 23.5M 16.8M
Cost Of Revenue 10.0M 7.2M 10.3M 6.8M
Gross Profit 9.6M 10.4M 13.2M 10.0M
Selling General And Administration 10.8M 10.1M 10.6M 8.7M
General And Administrative Expense 10.8M 10.1M -- --
Research And Development 646,000 699,000 609,000 634,000
Depreciation And Amortization In Income Statement 1.4M 1.5M 1.5M 1.4M
Operating Expense 12.8M 12.3M 12.7M 10.7M
Operating Income -3.2M -2.0M 529,000 -719,000
EBIT -2.7M -1.4M 562,000 -773,000
Interest Expense 65,000 85,000 158,000 236,000
Interest Expense Non Operating 65,000 85,000 158,000 236,000
Interest Income 496,000 507,000 260,000 182,000
Interest Income Non Operating 496,000 507,000 260,000 182,000
Net Interest Income 431,000 422,000 102,000 -54,000
Other Income Expense 20,000 4,000 -227,000 -236,000
Special Income Charges -- -- -- 0.00
Gain On Sale Of Security 67,000 -12,000 -170,000 -244,000
Earnings From Equity Interest -47,000 16,000 -57,000 8,000
Pretax Income -2.8M -1.5M 404,000 -1.0M
Tax Provision -14,000 456,000 -458,000 96,000
Tax Effect Of Unusual Items 339.36 -4,800 -44,557 -64,660
Net Income From Continuing And Discontinued Operation -2.8M -2.0M 862,000 -1.1M
Net Income From Continuing Operation Net Minority Interest -2.8M -2.0M 862,000 -1.1M
Net Income Including Noncontrolling Interests -2.8M -2.0M 862,000 -1.1M
Net Income Common Stockholders -2.8M -2.0M 862,000 -1.1M
Net Income -2.8M -2.0M 862,000 -1.1M
EBITDA -1.3M 61,000 2.0M 606,000
Normalized EBITDA -1.4M 73,000 2.2M 850,000
Reconciled Depreciation 1.4M 1.5M 1.5M 1.4M
Basic EPS -0.14 -0.10 0.04 -0.05
Diluted EPS -0.14 -0.10 0.04 -0.05
Basic Average Shares 19.4M 20.3M 20.7M 20.8M
Diluted Average Shares 19.4M 20.3M 21.0M 20.8M
Total Unusual Items 67,000 -12,000 -170,000 -244,000
Total Unusual Items Excluding Goodwill 67,000 -12,000 -170,000 -244,000
Tax Rate For Calcs 0.01 0.40 0.26 0.27
Normalized Income -2.8M -2.0M 987,443 -925,660
Depreciation Amortization Depletion Income Statement 1.4M 1.5M 1.5M 1.4M
Diluted NI Availto Com Stockholders -2.8M -2.0M 862,000 -1.1M
Impairment Of Capital Assets -- -- -- 0.00
Net Income Continuous Operations -2.8M -2.0M 862,000 -1.1M
Net Non Operating Interest Income Expense 431,000 422,000 102,000 -54,000
Other Gand A 5.4M 5.0M -- --
Reconciled Cost Of Revenue 10.0M 7.2M 10.3M 6.8M
Salaries And Wages 5.4M 5.2M -- --
Total Expenses 22.8M 19.5M 23.0M 17.5M
Total Operating Income As Reported -3.2M -2.0M 529,000 719,000
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 9.3M 9.4M 8.2M 11.3M
Cash Cash Equivalents And Short Term Investments 9.3M 9.4M 8.2M 11.3M
Accounts Receivable 1.4M 1.2M 4.6M 2.1M
Receivables 1.7M 2.8M 6.2M 3.7M
Inventory 4.1M 6.1M 5.6M 4.4M
Prepaid Assets 264,000 202,000 393,000 622,000
Current Assets 15.3M 18.5M 20.5M 20.1M
Gross PPE 5.0M 4.5M 4.7M 4.8M
Accumulated Depreciation -2.5M -2.6M -2.4M -2.2M
Net PPE 2.4M 1.8M 2.3M 2.6M
Goodwill And Other Intangible Assets 1.7M 2.0M 2.9M 3.7M
Other Intangible Assets 1.7M 2.0M 2.9M 3.7M
Investments And Advances 311,000 358,000 342,000 338,000
Long Term Equity Investment 311,000 358,000 342,000 338,000
Total Non Current Assets 6.5M 6.1M 8.0M 8.8M
Total Assets 21.8M 24.6M 28.5M 28.9M
Current Debt -- -- -- 976,000
Current Debt And Capital Lease Obligation 469,000 439,000 405,000 1.3M
Payables And Accrued Expenses 5.0M 4.3M 5.6M 5.3M
Other Current Liabilities 50,000 100,000 50,000 50,000
Current Liabilities 5.5M 4.9M 6.1M 6.7M
Long Term Debt And Capital Lease Obligation 365,000 815,000 1.2M 1.5M
Long Term Capital Lease Obligation 365,000 815,000 1.2M 1.5M
Other Non Current Liabilities 67,000 97,000 123,000 147,000
Total Non Current Liabilities Net Minority Interest 432,000 912,000 1.3M 1.7M
Total Liabilities Net Minority Interest 5.9M 5.8M 7.4M 8.4M
Common Stock 52.7M 54.3M 56.3M 58.1M
Capital Stock 52.7M 54.3M 56.3M 58.1M
Additional Paid In Capital 7.4M 6.0M 4.3M 2.8M
Retained Earnings -45.3M -42.6M -40.6M -41.5M
Gains Losses Not Affecting Retained Earnings 1.1M 1.1M 1.1M 1.1M
Other Equity Adjustments 1.1M 1.1M 1.1M 1.1M
Common Stock Equity 15.8M 18.8M 21.1M 20.5M
Stockholders Equity 15.8M 18.8M 21.1M 20.5M
Total Equity Gross Minority Interest 15.8M 18.8M 21.1M 20.5M
Total Capitalization 15.8M 18.8M 21.1M 20.5M
Net Tangible Assets 14.1M 16.8M 18.2M 16.8M
Tangible Book Value 14.1M 16.8M 18.2M 16.8M
Working Capital 9.8M 13.6M 14.5M 13.4M
Invested Capital 15.8M 18.8M 21.1M 21.5M
Total Debt 834,000 1.3M 1.6M 2.9M
Share Issued 19.1M 20.0M 20.3M 21.0M
Ordinary Shares Number 19.1M 20.0M 20.3M 21.0M
Allowance For Doubtful Accounts Receivable -92,000 -47,000 -54,000 -79,000
Capital Lease Obligations 834,000 1.3M 1.6M 1.9M
Current Capital Lease Obligation 469,000 439,000 405,000 367,000
Finished Goods 2.5M 3.0M 2.2M 1.2M
Gross Accounts Receivable 1.4M 1.2M 4.6M 2.2M
Investmentsin Associatesat Cost 311,000 358,000 342,000 338,000
Leases 617,000 617,000 617,000 617,000
Machinery Furniture Equipment 891,000 891,000 891,000 878,000
Non Current Accounts Receivable 1.4M 1.5M 1.6M 1.7M
Non Current Deferred Assets -- 0.00 455,000 0.00
Non Current Deferred Taxes Assets -- 0.00 455,000 0.00
Non Current Note Receivables 614,000 436,000 427,000 513,000
Other Current Borrowings -- -- -- 976,000
Other Properties 3.5M 2.9M 3.2M 3.3M
Other Receivables 226,000 1.6M 1.6M 1.5M
Properties 0.00 0.00 0.00 0.00
Raw Materials 984,000 2.5M 2.9M 2.6M
Taxes Receivable 133,000 21,000 101,000 145,000
Work In Process 564,000 589,000 512,000 594,000
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow 2.7M 2.1M -1.0M -1.6M
Cash Flow From Continuing Operating Activities 2.7M 2.1M -1.0M -1.6M
Depreciation And Amortization 1.4M 1.5M 1.5M 1.4M
Depreciation Amortization Depletion 1.4M 1.5M 1.5M 1.4M
Stock Based Compensation 181,000 82,000 221,000 272,000
Deferred Tax -14,000 456,000 -458,000 96,000
Deferred Income Tax -14,000 456,000 -458,000 96,000
Change In Working Capital 3.9M 1.8M -3.7M -2.7M
Changes In Account Receivables -82,000 3.4M -2.6M -1.0M
Change In Receivables 1.5M 3.7M -2.4M -2.1M
Change In Inventory 2.2M -917,000 -1.8M -1.4M
Change In Payables And Accrued Expense 430,000 -1.2M 232,000 993,000
Change In Other Current Assets -174,000 271,000 273,000 -267,000
Other Non Cash Items -146,000 -234,000 -103,000 74,000
Capital Expenditure -1.2M -133,000 -229,000 -346,000
Purchase Of PPE -1.2M -133,000 -229,000 -346,000
Net PPE Purchase And Sale -1.1M -133,000 -229,000 -346,000
Purchase Of Business -- 0.00 -61,000 0.00
Investing Cash Flow -2.0M -133,000 -290,000 -846,000
Cash Flow From Continuing Investing Activities -2.0M -133,000 -290,000 -846,000
Repayment Of Debt -441,000 -408,000 -1.4M -349,000
Net Issuance Payments Of Debt -441,000 -408,000 -1.4M -349,000
Repurchase Of Capital Stock -320,000 -393,000 -429,000 -101,000
Net Common Stock Issuance -320,000 -393,000 -429,000 -101,000
Common Stock Payments -320,000 -393,000 -429,000 -101,000
Financing Cash Flow -861,000 -782,000 -1.8M -500,000
Cash Flow From Continuing Financing Activities -861,000 -782,000 -1.8M -500,000
Effect Of Exchange Rate Changes 43,000 -14,000 63,000 -7,000
Changes In Cash -155,000 1.2M -3.2M -2.9M
Beginning Cash Position 9.4M 8.2M 11.3M 14.3M
End Cash Position 9.3M 9.4M 8.2M 11.3M
Free Cash Flow 1.5M 1.9M -1.2M -1.9M
Interest Paid Supplemental Data 45,000 61,000 107,000 163,000
Amortization Cash Flow 652,000 873,000 874,000 874,000
Amortization Of Intangibles 652,000 873,000 874,000 874,000
Asset Impairment Charge 258,000 438,000 526,000 440,000
Depreciation 714,000 633,000 597,000 505,000
Earnings Losses From Equity Investments 47,000 -16,000 57,000 -8,000
Gain Loss On Investment Securities -108,000 22,000 119,000 --
Gain Loss On Sale Of PPE -20,000 0.00 -- --
Long Term Debt Payments -441,000 -408,000 -373,000 -349,000
Net Business Purchase And Sale -- 0.00 -61,000 0.00
Net Income From Continuing Operations -2.8M -2.0M 862,000 -1.1M
Net Long Term Debt Issuance -441,000 -408,000 -373,000 -349,000
Net Other Financing Charges -100,000 -- -50,000 -50,000
Net Other Investing Changes -912,000 -- -- -500,000
Net Short Term Debt Issuance -- 0.00 -1.0M 0.00
Operating Gains Losses -81,000 6,000 176,000 -8,000
Proceeds From Stock Option Exercised 0.00 19,000 6,000 0.00
Sale Of PPE 78,000 0.00 -- --
Short Term Debt Payments -- 0.00 -1.0M 0.00
NEWS
Loading news...
TRENDING
Loading...